Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2013 Dec 1;20(3):326–336. doi: 10.1016/j.bbmt.2013.11.021

Figure 1. ENGRAFTMENT.

Figure 1

(a) Cumulative incidence of neutrophil engraftment > 500 cells/mm3 with donor cells by day 42

(b) Cumulative incidence of platelet engraftment > 50,000/mm3 by day 180 GVHD

(c) Cumulative incidence of acute GVHD, grades II–IV (solid line) and III–IV (dotted line)

(d) Cumulative incidence of chronic GVHD, overall (solid line) and extensive(dotted line)